All Updates

All Updates

icon
Filter
FDA approval
Industry news
Remilk gains regulatory approval from the SFA and FDA
Plant-based Dairy & Egg
Feb 23, 2023
This week:
Partnerships
Microsoft and BlackRock partner to launch USD 30 billion AI data center investment fund
Machine Learning Infrastructure
Yesterday
Funding
Limitless Labs raises USD 3 million in pre-seed funding to develop prediction market
Web3 Ecosystem
Yesterday
Product updates
Google Cloud launches Blockchain RPC service for Web3 developers
Web3 Ecosystem
Yesterday
Product updates
Kore.ai launches GALE platform for enterprise GenAI adoption
Machine Learning Infrastructure
Yesterday
Product updates
Kore.ai launches GALE platform for enterprise GenAI adoption
Generative AI Infrastructure
Yesterday
Partnerships
Climeworks partners with Terraset to enable philanthropic support for carbon removal
Carbon Capture, Utilization & Storage (CCUS)
Sep 17, 2024
Funding
8 Rivers secures investment from JX Nippon to commercialize DAC technology
Carbon Capture, Utilization & Storage (CCUS)
Sep 17, 2024
Product updates
ProAmpac launches enhanced online pouch configurator MAKR by DASL for custom flexible packaging prototypes
Smart Packaging Tech
Sep 17, 2024
Funding
M&A
Majority stake in Bollegraaf Group acquired by Summa Equity for EUR 800 million
Waste Recovery & Management Tech
Sep 17, 2024
Partnerships
NASA awards Intuitive Machines contract for near-space network services
Space Travel and Exploration Tech
Sep 17, 2024
Plant-based Dairy & Egg

Plant-based Dairy & Egg

Feb 23, 2023

Remilk gains regulatory approval from the SFA and FDA

FDA approval
Industry news

  • Remilk, an Israeli producer of plant-based dairy products through microbial fermentation, announced receiving regulatory approval from the Singapore Food Authority (SFA), as well as a “no questions” letter from the FDA.

  • The approval from the SFA will enable the sale of Remilk products in Singapore. While the company declared self-affirmed GRAS status in 2022 according to FDA protocols, the “no questions” letter from the FDA further establishes Remilk’s animal-free whey proteins as safe for consumption (following consensus from a panel of experts).

  • Analyst QuickTake: Both of these approvals are major milestones for Remilk, given that Singapore and the US are at the forefront of the alternative protein industry. Apart from the ability to sell its products, the company will be able to attract more investments and focus on R&D as regulatory approval—especially from the FDA—is seen as a variable that reduces the risk factor of a brand.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.